Analyst Ratings For NASDAQ:CRSP – CRISPR Therapeutics (NASDAQ:CRSP)
Today, Chardan Capital raised its price target on NASDAQ:CRSP – CRISPR Therapeutics (NASDAQ:CRSP) to per share.
Some recent analyst ratings include
- 4/6/2018-Goldman Sachs initiated coverage with a Buy ➝ Buy rating.
- 3/9/2018-SunTrust Banks Reiterated Rating of Buy.
- 3/9/2018-Piper Jaffray Reiterated Rating of Overweight.
- 3/8/2018-JMP Securities initiated coverage with a Mkt Outperform ➝ Outperform rating.
Recent Insider Trading Activity For NASDAQ:CRSP – CRISPR Therapeutics (NASDAQ:CRSP)
NASDAQ:CRSP – CRISPR Therapeutics (NASDAQ:CRSP) has insider ownership of 37.70% and institutional ownership of 36.73%.
- On 5/8/2018 Bradley J Phd Bolzon, Director, sold 128,950 with an average share price of $50.39 per share and the total transaction amounting to $6,497,790.50.
- On 4/30/2018 Bradley J Phd Bolzon, Director, sold 30,566 with an average share price of $50.29 per share and the total transaction amounting to $1,537,164.14.
- On 4/27/2018 Thomas Woiwode, Director, sold 222,258 with an average share price of $50.11 per share and the total transaction amounting to $11,137,348.38.
- On 4/24/2018 Versant Venture Capital V, L.P, Major Shareholder, sold 22,841 with an average share price of $50.99 per share and the total transaction amounting to $1,164,662.59.
- On 4/23/2018 Bradley J Phd Bolzon, Director, sold 101,994 with an average share price of $50.68 per share and the total transaction amounting to $5,169,055.92.
- On 1/16/2018 Tyler Dylan-Hyde, Insider, sold 66,000 with an average share price of $28.03 per share and the total transaction amounting to $1,849,980.00.
- On 1/5/2018 Aktiengesellschaft Bayer, Major Shareholder, bought 527,472 with an average share price of $22.75 per share and the total transaction amounting to $11,999,988.00.
Recent Trading Activity for NASDAQ:CRSP – CRISPR Therapeutics (NASDAQ:CRSP)
Shares of NASDAQ:CRSP – CRISPR Therapeutics closed the previous trading session at 56.28 down -0.50 0.88% with shares trading hands.